Novo Nordisk NVO has integrated its smart insulin pens, NovoPen 6 and NovoPen Echo Plus, with the Dexcom G7 continuous glucose monitoring system. This collaboration enables users to seamlessly ...

The new devices – NovoPen 6 and NovoPen Echo Plus – are insulin self-injection pens that record information such as when and how much insulin is administered, with the data uploaded to an app ...

DexCom DXCM recently signed a licensing and data partnership with a privately held healthcare-at-home digital diagnostics company — Nanowear. Per the terms of the agreement, Nanowear will use glucose ...

Today, the San Diego-based CGM maker announced that its G7 sensor directly connects with the NovoPen 6 and NovoPen Echo Plus in Germany. Novo Nordisk offers these smart, connected insulin pens. Dexcom ...

First, the company announced that its G7 sensor directly connects with Novo Nordisk’s NovoPen 6 and NovoPen Echo Plus in Germany. Additionally, the company highlighted new data for its 15-day CGM, ...

The global disposable insulin-delivery device market is projected to experience robust growth over the next decade, according to recent industry insights. Valued at USD 14,585.6 million in 2022, the ...